Halozyme Therapeutics Inc
NASDAQ:HALO
Wall Street
Price Targets
HALO Price Targets Summary
Halozyme Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
HALO
is 79.56 USD
with a low forecast of 58.58 USD and a high forecast of 96.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HALO's stock price target?
Price Target
79.56
USD
According to Wall Street analysts, the average 1-year price target for
HALO
is 79.56 USD
with a low forecast of 58.58 USD and a high forecast of 96.6 USD.
What is Halozyme Therapeutics Inc's Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Halozyme Therapeutics Inc's revenue is
26%.
The projected
CAGR
for the next 3 years is
13%.
What is Halozyme Therapeutics Inc's Operating Income forecast?
Projected CAGR
17%
The
compound annual growth rate
of Halozyme Therapeutics Inc's operating income for the next 3 years is
17%.
What is Halozyme Therapeutics Inc's Net Income forecast?
Projected CAGR
57%
The
compound annual growth rate
of Halozyme Therapeutics Inc's net income for the next 3 years is
57%.
